BridgeMD
Compares treatment options for Cutaneous Squamous Cell Carcinoma (CSCC)
Official title Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence
ClinicalTrials.gov ID: NCT06692556
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate a strategy integrating adjuvant radiation therapy versus strategy based on monitoring in the treatment of carcinomas spinocellular with high risk of recurrence (SCC). The investigators will compare the disease-free survival (DFS) of patients treated with adjuvant radiation therapy versus surveillance in high risk of recurrence SCC.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- I1. Patients aged ≥ 18 years at the time of signing the informed consent form; I2. Patients with histologically confirmed localized cutaneous...
- presence of microscopic EPN without any other risk factors;
- presence of microscopic EPN with a single other risk factor;
- presence of 2 risk factors other than microscopic EPN;
- presence of 3 risk factors other than microscopic EPN; Note: The risk factors considered are immunosuppression (limited to untreated hematologic...
You likely can't join if
- NI1. Patients with in situ or mixed CEC; NI2. History of CEC with a high risk of recurrence in the same lymphatic drainage area (head and neck...
- EPN with ≥ 2 other risk factors,
- \> 3 risk factors,
- bone invasion,
- immunosuppression due to immunosuppressive treatments (regardless of the reason). NI6. Patients with CEC presenting a single risk factor other than...
The study team makes the final eligibility decision.
Where it's taking place
- Le Puy-en-Velay, Auvergne-Rhône-Alpes, France
- Pierre-Bénite, Auvergne-Rhône-Alpes, France
- Dijon, Bourgogne-Franche-Comté, France
- Romans-sur-Isère, Drôme, France
- Valence, Drôme, France
- Brest, Finistère, France
- Pessac, Gironde, France
- Metz-Tessy, Haute-Savoie, France
- Rennes, Ille-et-Vilaine, France
- La Tronche, Isère, France
- Blois, Loir-et-Cher, France
- Nantes, Loire-Atlantique, France
- Reims, Marne, France
- Vandœuvre-lès-Nancy, MMeurthe-et-Moselle, France
- Lorient, Morbihan, France
- Bordeaux, New Aquitaine, France
- Le Havre, Normandy, France
- Roanne, Pays de la Loire Region, France
- Saint Priest En Jarez, Pays de la Loire Region, France
- Nice, Provence-Alpes-Côte d'Azur Region, France
+ 6 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Le Puy-en-Velay, Auvergne-Rhône-Alpes, France; Pierre-Bénite, Auvergne-Rhône-Alpes, France; Dijon, Bourgogne-Franche-Comté, France; Romans-sur-Isère, Drôme, France; Valence, Drôme, France; Brest, Finistère, France and 20 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.